Tixagevimab Uses, Dosage, Side Effects and more
Tixagevimab is under investigation in clinical trial NCT04625972 (Phase III Double-blind, Placebo-controlled Study of AZD7442 for Post- Exposure Prophylaxis of COVID-19 in Adults).
| Trade Name | Tixagevimab |
| Generic | Tixagevimab |
| Tixagevimab Other Names | Tixagevimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
